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ABSTRACT 
Objective: Cisplatin (CIS) consumption has become a common problem that affects the health of patients around the globe. Kidney has been 
suspected to be particularly susceptible to the destructive effects of CIS and nephrotoxic effects are still contentious which in turn affects the Quality 
of Life (QoL) of patients and increase the mortality rate. This study was conducted to investigate the nephroprotective effect of Noni Juice (NJ) and 
Divine Noni Gold (DNG) as herbal medicine with established antioxidant properties against the controversial nephrotoxic effect of CIS in mice. 
Methods: Mice were divided into four groups, each group contained six mice. Group I was kept as normal, Group II received CIS (5.0 mg/kg b. wt. i. p.) 
on day one for 14 d. Group III and IV received NJ (0.35 ml/mouse p. o.) and DNG (0.35 ml/mouse p. o.) respectively once daily for 14 d, Group V received 
CIS (5.0 mg/kg b. wt. i. p.) on day one and NJ (0.35 ml/mouse p. o.) once daily for 14 d. Similarly, Group VI received CIS (5.0 mg/kg b. wt. i. p.) on day one 
and DNG (0.35 ml/mouse p. o.) once daily for 14 d. On day 15 blood from all the mice was collected from the carotid vein and cardiac puncture routes, 
and the biochemical markers viz. lactate dehydrogenase (LDH), creatinine phosphokinase (CPK), and urea were assessed. Kidney from all the animals 
was isolated, and catalase (CAT), glutathione (GSH), superoxide dismutase (SOD), thiols and lipid peroxidase (LPO) were estimated. 
Results: CIS-induced marked kidney injury; congestion of tubules, glomerular distortion foci, thickened and blocked blood vessels. Also showed 
significant elevation of LDH, CPK, and urea with significant inhibition of CAT, GSH, SOD, thiols activities and simultaneously elevation of LPO level. 
Co-administration of NJ and DNG respectively with CIS protected kidney tissues via oxidative stress inhibition.  
Conclusion: NJ and DNG possess protective effect against CIS-induced cellular damage in the kidney by decreasing the level of serum biochemical 
markers, enhancing the level of enzymatic and non-enzymatic antioxidants and maintaining the LPO level. Results suggest that NJ and DNG have 
strong nephroprotective effect against CIS-induced nephrotoxicity. 
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CIS is an antineoplastic agent, widely used in various human 
malignancies which include head, neck, lung, ovary, bladder, testis, and 
cervical areas [1]. Nephrotoxicity, GI-toxicity, myelotoxicity, testicular 
toxicity, cardiotoxicity, hepatotoxicity, immunotoxicity, peripheral 
nerve toxicity and genotoxicity are some of the observed adverse 
effects [2, 3]. A total of 20% patients are receiving a high dose of CIS 
has severe renal dysfunction where it intercalates double-strand DNA 
cross-links causing cytotoxic lesions in malignant as well as normal 
cells [4]. Generally, DNA damaging agents have less toxicity on non-
proliferating cells, yet the proximal tubule cells are selectively 
damaged by CIS because of its accumulation in the kidney to a greater 
extent compared to other organs [5]. Suggests that this injury is due to 
inflammation, oxidative stress and apoptosis [6].  
Several studies have shown that revelation to CIS interrupts the 
redox balance of tissues, directly act on cell components, including 
lipids, proteins, and DNA, suggesting that biochemical and 
physiological disturbances result from oxidative stress [7, 8]. 
Various studies have reported that signaling pathways are involved in 
modulating cell survival or apoptosis in response to DNA damage 
induced by CIS [9] and these signaling pathways can also be activated 
by oxidative stress and lipid peroxidation [10, 11]. CIS engenders 
superoxide anion radical (SAR) and hydroxyl radical (OH-) which 
decline the level of GSH and inhibit the activity of antioxidant enzymes 
in renal tissue. Reactive Oxygen Species (ROS) may produce cellular 
injury and necrosis via several mechanisms including peroxidation of 
membrane lipids, denaturation of protein and DNA damage [12]. 
It has been suggested that CIS-induced oxidative stress through the 
generation of ROS which leads to decrease the level of enzymatic and 
non-enzymatic antioxidants and thereby induces normal cell 
damage [13]. In this regard, CIS injury can be ameliorated by free 
radical scavengers [14, 15], iron chelators [16], SOD [17], CAT [18], 
GSH [19], LPO [20], selenium and vitamins [21]. Since CIS elevates 
the LPO level and decreases endogenous antioxidants levels, free 
radical scavengers and in vivo antioxidants can be effective against 
CIS-induced toxicities. 
Noni (Morinda citrifolia L. family Rubiaceae) is one of the traditional 
folk medicinal plant [22]. The plant has been shown to have potent 
antioxidant activity both in vitro and in vivo studies [23]. Noni fruit is 
rich in phenolic compounds like ellagic acid, gallic acid, quercetin, 
rutin, rosmarinic acid, caffeic and chlorogenic acid which are highly 
potent antioxidant. EGCg is a polyphenolic flavonoid antioxidant found 
in abundance in noni fruit having antioxidant properties which inhibit 
the quinol oxidase (NOX). NOX enzymes are found in various types of 
cells and tissues where they react with oxygen to generate ROS, the 
free radical forms of oxygen that damage the DNA of normal cell [24]. 
Antioxidants maintain free radicals into balance thus lowering the 
risk of oxidative stress. It is well documented that many herbal 
antioxidants reduced the toxicity due to oxidative stress, elicited by 
several medications and prevent the damage to normal cells [25-27]. 
There is additionally sensible evidence that antioxidants reversed 
nephrotoxicity caused by oxidative stress due to one or the other 
reasons. Reported that antioxidants protected the kidney cells from 
the toxicity elicited by CIS [28-30].  
NJ and DNG has been proven potent antioxidants and used as health 
tonics can protect the kidney cells by CIS toxicity. So in the light of 
above reports and evidence, the present study aims to evaluate the 
possible protective effect of NJ and DNG against CIS-induced 
nephrotoxicity in mice. 
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MATERIALS AND METHODS 
Chemicals and diagnostic kits 
Cisplatin hydrochloride injection 50 mg/50 ml vial was procured from 
JSS Hospital, Mysuru, India. The kits of LDH, CPK and urea, were 
purchased from Merck Specialities Pvt. Ltd. India. 1,1-3,3-
tetramethoxypropane, 5,5-dithiobis-2-nitrobenzoic acid (DTNB), GSH 
powder, horseradish peroxidase, N-(1-Naphthyl) ethylenediamine 
dihydrochloride, o-dianisidine hydrochloride, thiobarbituric acid (TBA), 
malondialdehyde (MDA), trichloroacetic acid (TCA) tris-hydroxy-
methylamino methane was purchased from Sigma-Aldrich (USA).  
Noni products 
The ripe noni fruits and DNG concentrate were procured from Noni 
Biotech Pvt. Ltd. Tamil Nadu, India. Fresh NJ was prepared from fully 
ripped noni fruit by hand squeezing method. 
Animals 
The inbred Swiss albino mice were procured from central animal 
house facility of JSS Medical College, Mysuru, India, were used for all 
the experiments. This experimental study was approved by 
Institutional Animal Ethical Committee (IAEC) of JSS College of 
Pharmacy, JSS University, Mysuru. Animal care and handling were 
done according to the CPCSEA guidelines. The animals were fed 
commercial nutritional pellets and tap water/ad libitum.  
Experimental design 
Mice were divided into six groups each group contained six mice and 
subjected to various daily treatment regimens:  
Group-I: Normal mice. Group-II (CIS): Mice received CIS (5.0 mg/kg 
b. wt. i. p) [31] on day one. Group-III (NJ): Mice received NJ (0.35 
ml/mouse p. o.) once daily for 14 d. Group-IV (DNG): Mice received 
DNG (0.35 ml/mouse p. o.) once daily for 14 d. The dose of NJ and 
DNG were calculated according to the following formula; Human 
adult dose * body surface area ratio convertible factor of mouse 
=133 ml * 0.0026 = 0.3458 ml [32, 33] Group-V (NJ+CIS): Mice 
received NJ (0.35 ml/mouse p. o.) once daily for 14 d+CIS (5.0 mg/kg 
b. wt. i. p.) on day one after 30 min of NJ administration. Group-VI 
(DNG+CIS): Mice received DNG (0.35 ml/mouse p. o.) once daily for 
14 d+CIS (5.0 mg/kg b. wt. i. p.) on day one after 30 min of DNG 
administration. 
Parameters assessed  
After 14 d dosing as represented earlier, on day 15 blood was 
withdrawn from carotid bleeding and cardiac puncture routes for 
the estimation of serum biochemical markers (LDH, CPK, and urea) 
were estimated using commercially available kits (Merck Pvt. Ltd.) 
in semi auto analyzer. After withdrawal blood, animals were 
sacrificed humanely using ketamine anesthesia. Animals were then 
cut opened, and transcardial perfusion was performed with a 
minimum of 100 ml/mouse using phosphate buffer. The kidneys 
were dissected out, blotted, dried and weighed for the assessment of 
nephrotoxicity. 
Nephrotoxicity 
A part of each kidney were cut and fixed in 10% formalin for 
histopathological studies. The remaining part was used for 
endogenous enzymatic and non-enzymatic antioxidant estimation. A 
10% homogenate was prepared with ice cold phosphate buffer and 
used for the estimation of GSH [34], CAT [35], SOD [36], total thiol 
[37] and LPO [38]. 
RESULTS 
Nephroprotective study 
A single dose of CIS (5.0 mg/kg b. wt. i. p.) in group-II, caused 
significant (p<0.001) elevation in the level of serum biochemical 
markers (LDH, CPK, and urea). Co-administration of NJ and DNG 
(0.35 ml/mouse p. o.) respectively induced significant (p<0.001) 
reduction in the elevation the above biochemical markers in CIS 
challenged mice (Group-V and VI). Whereas NJ and DNG respectively 
(Group-III and IV) showed no significant difference compared to 
normal (Group-I), (fig. 1). 
  
 
[A]       [B] 
 
[C] 
Fig. 1: Effect of NJ and DNG treatment on serum toxicological and diagnostic markers in mice challenged with a single dose of CIS (5.0 
mg/kg b. wt.). All the values are mean±SEM of six mice, ***ap<0.001 compared to normal, ***bp<0.001 compared to CIS, ***cp<0.001 
compared to NJ, ***dp<0.001 compared to DNG, ***ep<0.001 compared to NJ+CIS 
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At the similar dose of CIS also decreased the levels of SOD, CAT, GSH 
and thiols while LPO level was simultaneously increased.  
Co-administration of NJ and DNG respectively at a dose 0.35 
ml/mouse significantly (p<0.001) decreased elevation in LPO and 
maintained SOD, GSH, CAT, and thiols concentrations near to normal 
in CIS challenged mice (Group-V and VI). In this study, DNG showed 
a more protective effect when compared to NJ in both serum 
biochemical markers (fig. 1) and endogenous enzymatic and non-








Fig. 2: Status of kidney enzymatic and non-enzymatic antioxidants levels in mice treated with NJ and DNG (0.35 ml/mouse) respectively 
with CIS (5.0 mg/kg b. wt.). All the values are mean±SEM of six mice, ***ap<0.001 compared to normal, ***bp<0.001 compared to CIS, 
***cp<0.001 compared to NJ,***dp<0.001 compared to DNG, ***ep<0.001 compared to NJ+CIS 
 
Histopathological study 
The normal kidney section (fig. 3; A.) revealed normal histology of 
glomerulus, distal and proximal convoluted tubules and normal 
orientation of nephrons. Similar results were obtained in the 
treatment of NJ and DNG (0.35 ml/mouse p. o.) respectively in 
normal mice (fig. 3; C, D). Light microscopic observations of CIS at 
the dose of 5.0 mg/kg b. wt. i. p caused necrosis and thickened blood 
vessels. The dead and inflammatory cells were increased, also 
glomerular and tubular congestion was observed (fig. 3: B).  
Co-administration of NJ and DNG (0.35 ml/mouse p. o.) respectively 
induced significant changes, reduced thickened of blood vessels, 
moderate glomerular and tubular congestion, less necrosis, and 
inflammatory and dead cells in proximal renal tubules in CIS treated 
mice was noted as well (fig. 3; E, F). 
DISCUSSION 
The cytotoxic effect of CIS is believed to result mainly from its 
interaction with DNA via the formation of covalent adducts between 
certain DNA bases and platinum compounds [39]. CIS-induced 
nephrotoxicity can result in severe renal tubular injury leading to 
acute renal failure [40]. The CIS concentration in proximal tubular 
epithelial cells is about 5 times more than serum concentration. The 
disproportionate accumulation of CIS in kidney tissues contributes 
to CIS-induced nephrotoxicity manifested by an elevation in serum 
creatinine, urea and LDH levels [41]. Reported that CIS-induced 
inflammation, oxidative stress injury and apoptosis which probably 
clarifies kidney damage [42]. 
Free radical mediated reactions are responsible for a wide range of 
chemotherapy-induced side effects, and antioxidants are able to 
protect non-malignant cells against the destruction by cytostatic 
agents [43]. The antioxidants can play in protecting against CIS-
induced toxicity in mammalian systems [44, 45]. However, little is 
known about the interaction of antitumor drugs with antioxidants 
[46]. The results of the estimation of serum biochemical markers 
and endogenous enzymatic and non-enzymatic antioxidants data 
clearly revealed that NJ and DNG significantly reduced the 
nephrotoxic effect induced by CIS which is confirmed by 
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histopathological study. Natural antioxidants have been broadly 
used for chemo protection assuming that they detoxify ROS and 
prevent untoward effects produced by antineoplastic agents and 









Fig. 3: Histopathological analysis of the kidney [Hematoxylin and Eosin (H and E) stain]. The kidney was mined on day 15 after 
commencing the treatment. These images are representative of observations made on 6 mice/group. (Scale bar: 5 μm), [A] Normal kidney 
section is showing the normal renal morphology of predominant tubules, glomerulus, afferent and efferent arterioles, [B] Mice treated 
with CIS is showing renal tissue with predominant tubular foci, congested tubules, admixed with glomerular distortion foci and thickened 
and blocked blood vessels, [C] Treated with NJ is showing normal renal tissue with normal, arterioles, tubular and glomerular pattern, [D] 
Treated with DNG is showing renal tissue with normal tubular and glomerular foci. Fig. [E] NJ with CIS protected kidney tissues and is 
showing normal glomerular and tubular renal tissues with normal architecture, [F] DNG with CIS protected kidney tissues and is showing 
predominantly normal renal morphology with normal tubular and glomerular foci 
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Reported that NJ has a high antioxidant potential along with 
cytotoxic activity on cancer cells. Consuming 1 to 4 oz (1 oz = 30 ml) 
of Tahitian Noni Juice (TNJ) daily may reduce the cancer risk in 
heavy cigarette smokers by blocking carcinogen-DNA binding [48]. 
Mani and their colleagues reported that NJ treatment significantly 
increased antioxidant enzymes levels such as CAT, SOD and 
significantly decreased LPO level in liver and kidney tissues when 
compared to n-methyl-n-nitrosourea (NMU) induced mammary 
carcinogenesis in Sprague-Dawley rats. NJ showed a preventive 
effect against anemia, lymphocytosis, and neutrophilia when 
compared to NMU control group. Overall they suggest that NJ 
reduces the adverse effects of NMU carcinogenesis by antioxidant 
properties [49]. The result of the present study is in accordance with 
the aforesaid study [48] and [49].  
Co-administration of plant extracts with CIS can prevent/minimize 
the toxicity [50, 51]. Moreover, the decline of SOD, CAT and GSH 
activities was revealed after CIS (5.0 mg/kg b. wt. i. p.) treatment in 
the present study, resulting in the abridged ability of the kidney to 
scavenge toxic H2O2, O2 − and lipid peroxides (Group II). Co-
administration of NJ and DNG respectively with CIS were able to 
maintain SOD, CAT, GSH, thiols and LPO activities in kidney tissues 
(fig. 2). These results are in agreement with Bae et al. [52]. 
CIS-induced nephrotoxicity was clearly observed through significant 
elevation of LDH, CPK, and urea levels in CIS treated mice compared 
with normal which significantly (p<0.001) diminished the elevated 
levels and maintained close to normal when NJ and DNG 
administered respectively with CIS (fig. 1). This may be attributed to 
noni components which may stabilize kidney cells and prevent the 
release of serum biomarkers to the extracellular fluid. Concerning the 
histopathological changes the kidney damage produced by CIS (5.0 
mg/kg b. wt. i. p.) to mice caused the extent of renal tissue with 
predominant congested tubular foci, admixed with glomerular 
distortion foci of necrosis and thickened blood vessels (fig. 3; B) which 
are significantly reduced by co-administration of NJ and DNG 
respectively with CIS (fig. 3; E and F).  
Results obtained in the present in vivo study motivated us to initiate 
the possible protective effect of NJ and DNG against CIS-induced 
toxicity in experimental animals. Nephroprotective effects of NJ and 
DNG may be due to the presence of their distinctive 
phytoconstituents. NJ and DNG are highly rich in phenolic 
compounds like rutin, quercetin, flavonol glycosides, gallic acid, 
tannins, sterol, etc. Flavonoids present in noni fruit have been 
reported to possess both antioxidant and anti-inflammatory 
activities via free radical scavenging as well as inhibition of oxidases 
and LPO [53].  
In the phytochemical analysis, DNG revealed the presence of more 
amount of chemical constituents than NJ. DNG is a marketed 
formulation obtained from noni fruit juice mixed with the extract of 
garcinia cambogia and glycyrrhiza glabra and mixed with vit. A, B, C, 
and some minerals that could be one of the reasons for DNG showing 
more additive and protective effect than fresh NJ. The present study 
demonstrated that NJ and DNG provided a significant protective 
effect against CIS-induced nephrotoxicity when administered in 
combination with CIS and the mechanism of these protective effects 
of NJ and DNG could be due to their antioxidant, anti-inflammatory 
and free radical scavenging activities.  
CONCLUSION 
Oxidative stress plays a major role in CIS-induced nephrotoxicity 
throughout the conventional clinical regimens of treatment. 
Antioxidants have evidenced to be effective in ameliorating CIS-
induced toxicity in abundant preclinical and few clinical 
interventions. NJ and DNG have a potent antioxidant activity which 
is reported in this study i.e. nephroprotective effect. Co-
administration of NJ and DNG respectively with CIS provided almost 
a complete protection in terms of plasma biochemical, endogenous 
enzymatic and non-enzymatic antioxidants changes, and organs 
histological changes. The findings of the present study provide an 
insight and justifies for the use of NJ and DNG as an adjuvant therapy 
with CIS to attenuate CIS-induced nephrotoxicity. 
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